- Oral presentation
- Open Access
Breast clinic referrals – should mastalgia be managed in primary care?
© Alamiri et al; licensee BioMed Central Ltd. 2013
- Published: 30 January 2013
- Public Health
- Breast Cancer
- Primary Care
- Care Setting
- Normal Breast
Following centralisation of breast cancer services in Ireland, the number of patients attending symptomatic breast units (SBU) has increased significantly. A considerable proportion of patients referred to SBU present with non-suspicious symptoms and fall into a “low-risk” category for breast cancer. It has been proposed that consideration be given to a GP-delivered service for these patients. Aim: To evaluate SBU attendances and correlate with diagnosis to identify a cohort of patients who may be suitable for management in the primary care setting.
Data was collected from a prospectively maintained database on patients attending SBU at Beaumont Hospital from January 2011 – May 2012. Reasons for attendance, outcome of triple-assessment and incidence of malignancy were analysed.
Findings: 6,019 patients underwent triple-assessment at the SBU in this time-period. 1,959 patients were referred with mastalgia, of whom 1,022 (52.2%) reported mastalgia as their only symptom. The incidence of breast cancer in patients presenting with mastalgia alone was 0.8%; all patients diagnosed with breast cancer in this cohort were over 40 years of age. There was no breast cancer diagnosed in patients under 35yrs referred to SBU with mastalgia, and the majority of these patients had a normal breast examination (S2) (82.57%).
The incidence of breast cancer in patients referred to SBU with mastalgia as an isolated symptom is extremely low. Patients under-35yrs, with mastalgia as an isolated symptom do not require breast imaging and have a sufficiently low risk of breast cancer that they may be suitable for management in the primary-care setting.
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.